Tcelltech Inc.
Clinical trials sponsored by Tcelltech Inc., explained in plain language.
-
First human trial tests engineered immune cells against tough cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cancer treatment called TX103 CAR-T cell therapy in adults with advanced solid tumors that have a specific protein marker. The main goals are to check if the treatment is safe, find the right dose, and see if it shows any signs of f…
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New immune cell therapy tested for aggressive brain cancer
Disease control Recruiting nowThis is an early-stage trial testing a new type of personalized immune cell therapy called TX103 CAR-T in adults with a specific, aggressive brain cancer (grade 4 glioma) that has returned or worsened after standard treatment. The main goal is to find a safe dose and see how well…
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC